Aorto-Iliac Occlusive Disease Treatment Market Projected to Reach USD 3.56 Billion by 2034, Growing at a CAGR of 5.3%

Global aorto-iliac occlusive disease (iliac disease) treatment market size and share is currently valued at USD 2.12 billion in 2024 and is anticipated to generate an estimated revenue of USD 3.56 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034

Market Definition

This market involves treatments for aorto-iliac occlusive disease, where blockages occur in the aorta and iliac arteries, often due to atherosclerosis. Treatments include angioplasty, stenting, bypass surgery, and drug therapies. Increasing prevalence of peripheral artery disease (PAD), rising geriatric population, and lifestyle-related risk factors like smoking and diabetes drive demand. Hospitals and vascular surgery centers are key end-users. Technological advancements in minimally invasive procedures and imaging tools support market expansion. However, high treatment costs, limited access in rural areas, and postoperative complications pose challenges. Preventive healthcare awareness and improved diagnostic capabilities are essential for future market growth.

Key Report Highlights

The report highlights the key region that accounts for the highest revenue share in the global Aorto-Iliac Occlusive Disease Treatment market.
It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
The report outlines the dominant segment that holds a major share of the market.
It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

Market Value in 2024: USD 2.12 billion
Projected Market Size in 2034: USD 3.56 billion
Anticipated CAGR (2025-2034): 5.3%

Get access to the full report or request a complimentary sample for in-depth analysis:

https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-sample

Market Growth Drivers

The market for treating aorto-iliac occlusive disease is driven by the increasing prevalence of peripheral artery disease (PAD), often exacerbated by aging populations, diabetes, and smoking. Minimally invasive procedures such as angioplasty and stenting have gained traction due to reduced recovery times and improved outcomes. Advances in imaging and catheter-based interventions enhance early diagnosis and effective treatment. Rising awareness of cardiovascular health and increased availability of vascular surgeons and specialized clinics are improving patient access to care. Furthermore, continuous technological innovation in stents and drug-eluting devices is elevating treatment efficacy, thereby driving market expansion globally.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include